XENOPORT INC Contracts & Agreements
132 Contracts & Agreements
- Business Finance (36 contracts)
- Business Operations (15)
- Human Resources (39)
- Intellectual Property (3)
- Mergers & Acquisitions (1)
- Real Estate (3)
- Uncategorized (35)
- AGREEMENT AND PLAN OF MERGER (Filed With SEC on May 23, 2016)
- LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on May 5, 2016)
- XENOPORT, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on February 26, 2016)
- Named Executive Officer Compensation Information 2016 Salaries and Target Bonus Percentages (Filed With SEC on January 29, 2016)
- XENOPORT, INC. EMPLOYEE RETENTION BONUS AGREEMENT (Filed With SEC on January 29, 2016)
- XENOPORT, INC. (Filed With SEC on October 1, 2015)
- XENOPORT, INC. (Filed With SEC on October 1, 2015)
- SEVERANCE RIGHTS AGREEMENT A-1 SEVERANCE RIGHTS AGREEMENT (Filed With SEC on October 1, 2015)
- AMENDED OFFERING DOCUMENT XENOPORT, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN OFFERING DOCUMENT ADOPTED BY THE BOARD OF DIRECTORS:JUNE 12, 2015 (Filed With SEC on August 6, 2015)
- XENOPORT, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 27, 2015 APPROVED BY THE STOCKHOLDERS:MAY 19, 2015 (Filed With SEC on May 22, 2015)
- XENOPORT, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN OFFERING DOCUMENT ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 27, 2015 (Filed With SEC on May 22, 2015)
- THIRD AMENDMENT TO LEASE (Filed With SEC on February 27, 2015)
- Executive Officer Compensation Information 2015 Salaries and Target Bonus Percentages (Filed With SEC on February 27, 2015)
- XENOPORT, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of February 3, 2015 2.50% Convertible Senior Notes due 2022 TABLE OF CONTENTS (Filed With SEC on February 3, 2015)
- AMENDMENT NO. 1 TO RIGHTS AGREEMENT (Filed With SEC on February 3, 2015)
- Named Executive Officer Compensation Information 2015 Salaries and Target Bonus Percentages (Filed With SEC on January 16, 2015)
- XenoPort, Inc. Corporate Bonus Plan Adopted January 30, 2007 Effective January 1, 2007 Amended and Restated, Effective June 1, 2012 Amended and Restated, Effective January 1, 2015 (Filed With SEC on January 16, 2015)
- CHANGE OF CONTROL AGREEMENT (Filed With SEC on August 7, 2014)
- XENOPORT, INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (INITIAL GRANT) (Filed With SEC on August 7, 2014)
- XENOPORT, INC. NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNITGRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on August 7, 2014)
- DIRECTOR COMPENSATION POLICY XENOPORT, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY ADOPTED BY THE BOARD OF DIRECTORS:MARCH 17, 2014 APPROVED BY STOCKHOLDERS:JUNE 11, 2014 (Filed With SEC on August 7, 2014)
- LICENSE AGREEMENT (Filed With SEC on June 24, 2014)
- XENOPORT, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:FEBRUARY 21, 2014 APPROVED BY THE STOCKHOLDERS:JUNE 11, 2014 (Filed With SEC on June 16, 2014)
- XENOPORT, INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on June 16, 2014)
- XENOPORT, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on June 16, 2014)
- CHANGE OF CONTROL AGREEMENT (Filed With SEC on May 9, 2014)
- Executive Officer Compensation Information 2014 Salaries and Target Bonus Percentages (Filed With SEC on February 28, 2014)
- 12,000,000 Shares XENOPORT, INC. CommonStock (par value $0.001 per share) UNDERWRITING AGREEMENT (Filed With SEC on January 24, 2014)
- Named Executive Officer Compensation Information 2014 Salaries and Target Bonus Percentages (Filed With SEC on January 17, 2014)
- MASTER MANUFACTURING AND SUPPLY AGREEMENT BETWEEN XenoPort, Inc., AND PatheonPharmaceuticals Inc., DATED AS OF September 25, 2013. TABLE OF CONTENTS (Filed With SEC on November 8, 2013)
- Non-Employee Director Compensation Program Effective July 1, 2013 (Filed With SEC on August 7, 2013)
- LEASE AMENDMENT AND TERMINATION AGREEMENT (Filed With SEC on March 14, 2013)
- AMENDED & RESTATED SEVERANCE RIGHTS AGREEMENT (Filed With SEC on March 14, 2013)
- CERTAIN CONFIDENTIALINFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITHTHE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THESECURITIES... (Filed With SEC on March 14, 2013)
- STOCK PURCHASE AGREEMENT (Filed With SEC on March 14, 2013)
- Named Executive Officer Compensation Information 2013 Salaries and Target Bonus Percentages (Filed With SEC on January 14, 2013)
- SECOND AMENDMENT TO LEASE (Filed With SEC on October 25, 2012)
- SEVERANCE RIGHTS AGREEMENT (Filed With SEC on August 8, 2012)
- XenoPort, Inc. Corporate Bonus Plan Adopted January 30, 2007 Effective January 1, 2007 Amended and Restated, Effective June 1, 2012 (Filed With SEC on August 8, 2012)
- 6,153,846 Shares XENOPORT, INC. Common Stock (par value $0.001 per share) UNDERWRITING AGREEMENT (Filed With SEC on July 26, 2012)
- XENOPORT, INC. 2005NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN ADOPTED: JANUARY 4, 2005 APPROVED BY STOCKHOLDERS: JANUARY 19, 2005 FIRST AMENDMENT: MAY 1, 2012 (Filed With SEC on May 8, 2012)
- XENOPORT, INC. 2005NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN STOCK OPTION AGREEMENT (NONSTATUTORY STOCK OPTION) (Filed With SEC on May 8, 2012)
- XENOPORT, INC. 2005EQUITY INCENTIVE PLAN NON-EMPLOYEEDIRECTOR STOCK UNIT AWARD AGREEMENT (Filed With SEC on May 8, 2012)
- Non-Employee Director Compensation Program Effective May 1, 2012 (Filed With SEC on May 8, 2012)
- CERTAIN CONFIDENTIAL INFORMATION CONTAINED INTHIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGECOMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES... (Filed With SEC on February 29, 2012)
- SEVERANCE RIGHTS AGREEMENT (Filed With SEC on February 10, 2012)
- SEVERANCE RIGHTS AGREEMENT (Filed With SEC on February 10, 2012)
- Named Executive Officer Compensation Information 2012 Salaries and Target Bonus Percentages (Filed With SEC on January 17, 2012)
- XENOPORT, INC. 2010INDUCEMENT AWARD PLAN ADOPTED: MAY 11,2010 FIRST AMENDMENT: EFFECTIVE AUGUST 1, 2011 (Filed With SEC on August 5, 2011)
- AMENDED AND RESTATED CHANGE OF CONTROL AGREEMENT (Filed With SEC on March 1, 2011)
- CERTAIN CONFIDENTIAL INFORMATION CONTAINED INTHIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGECOMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES... (Filed With SEC on March 1, 2011)
- Named Executive Officer Compensation Information 2011 Salaries and Target Bonus Percentages (Filed With SEC on January 14, 2011)
- 4,000,000 Shares XENOPORT, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENT (Filed With SEC on December 9, 2010)
- Exhibit A Equity Awards as of September 16, 2010 (Filed With SEC on November 9, 2010)
- CHANGE OF CONTROL AGREEMENT (Filed With SEC on November 9, 2010)
- PERFORMANCE STOCK UNIT AGREEMENT (Filed With SEC on August 6, 2010)
- PERFORMANCE STOCK UNIT AGREEMENT (Filed With SEC on August 6, 2010)
- Named Executive Officer Compensation Information 2010 Salaries and Target Bonus Percentages (Filed With SEC on May 10, 2010)
- Named Executive Officer Compensation Information 2010 Salaries and Target Bonus Percentages (Filed With SEC on January 19, 2010)
- CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT,MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSIONPURSUANT TO RULE 24B-2 OF THE SECURITIES... (Filed With SEC on November 4, 2009)
- CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BYBRACKETS, IS FILED WITH THE SECURITIESAND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES... (Filed With SEC on August 6, 2009)
- Exhibit No (Filed With SEC on July 8, 2009)
- CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKEDBY BRACKETS, IS FILED WITH THESECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE (Filed With SEC on May 7, 2009)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on February 2, 2009)
- Named Executive Officer Compensation Information 2008 Bonus Awards (Filed With SEC on January 16, 2009)
- XENOPORT, INC. WARRANT TO PURCHASE [____] SHARES OF COMMON STOCK (Filed With SEC on December 30, 2008)
- PURCHASE AGREEMENT (Filed With SEC on December 30, 2008)
- In thousands (Filed With SEC on August 7, 2008)
- In thousands (Filed With SEC on August 7, 2008)
- In thousands (Filed With SEC on August 7, 2008)
- In thousands (Filed With SEC on August 7, 2008)
- In thousands (Filed With SEC on August 7, 2008)
- In thousands (Filed With SEC on May 8, 2008)
- In thousands (Filed With SEC on May 8, 2008)
- In thousands (Filed With SEC on May 8, 2008)
- In thousands (Filed With SEC on May 8, 2008)
- Executive Compensation Information (Filed With SEC on February 1, 2008)
- in thousands (Filed With SEC on November 9, 2007)
- in thousands (Filed With SEC on November 9, 2007)
- in thousands (Filed With SEC on November 9, 2007)
- in thousands (Filed With SEC on November 9, 2007)
- in thousands (Filed With SEC on November 9, 2007)
- in thousands (Filed With SEC on November 9, 2007)
- in thousands (Filed With SEC on November 9, 2007)
- in thousands (Filed With SEC on November 9, 2007)
- in thousands (Filed With SEC on November 9, 2007)
- in thousands (Filed With SEC on August 9, 2007)
- In thousands (Filed With SEC on May 9, 2007)
- In thousands (Filed With SEC on May 9, 2007)
- XP13512 for RLS. XP13512 is a Transported Prodrug of gabapentin. XP13512 is currently being evaluated in a Phase 3 clinical program for the treatment of RLS. RLS is characterized... (Filed With SEC on March 7, 2007)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on February 2, 2007)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on February 2, 2007)
- Term Sheet for Director Cash Compensation (Filed With SEC on August 4, 2006)
- Underwriting Agreement, dated June 21, 2006 (Filed With SEC on June 22, 2006)
- Exhibits and Financial Statement Schedules (Filed With SEC on June 20, 2006)
- XenoPort, Inc. Executive Officer Bonus Plan (Filed With SEC on February 1, 2006)
- Executive Compensation Information (Filed With SEC on February 1, 2006)
- FORM OF RIGHT CERTIFICATE (Exhibit B to Rights Agreement) Certificate No. R- ___Rights (Filed With SEC on December 16, 2005)
- XENOPORT, INC. and MELLON INVESTOR SERVICES LLC, as Rights Agent RIGHTS AGREEMENT Dated as of December 15, 2005 (Filed With SEC on December 16, 2005)
- Distribution and License Agreement, dated as of December 1, 2005, between XenoPort, Inc. and Astellas Pharma Inc (Filed With SEC on December 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)
- Common stock offered (Filed With SEC on January 19, 2005)